Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$920K Buy
10,875
+80
+0.7% +$6.45K 0.02% 753
2026
Q1
$763K Buy
10,795
+88
+0.8% +$6.59K 0.02% 760
2025
Q4
$845K Buy
10,707
+437
+4% +$34.6K 0.02% 688
2025
Q3
$846K Buy
10,270
+1,553
+18% +$122K 0.02% 635
2025
Q2
$701K Buy
8,717
+173
+2% +$13.3K 0.02% 598
2025
Q1
$686K Buy
8,544
+601
+8% +$50K 0.03% 539
2024
Q4
$650K Buy
+7,943
New +$661K 0.02% 558
2019
Q1
Sell
-758
Closed -$31K 1140
2018
Q4
$31K Sell
758
-10,508
-93% -$451K 0.01% 780
2018
Q3
$526K Buy
+11,266
New +$515K 0.25% 113
2018
Q1
$579K Sell
12,616
-1,078
-8% -$52.3K 0.27% 104
2017
Q4
$692K Buy
+13,694
New +$721K 0.32% 80

Other funds holding MET

MGO One Seven's MET Position: Q2 2026 in Review

MGO One Seven increased its MetLife (MET) stake by 0.74% in Q2 2026, buying an estimated $6.45K and bringing the position to 10,875 shares worth $920K. The position accounts for 0.02% of the portfolio, ranked #753.

MGO One Seven first reported a position in MET in Q4 2017 and has held it in 11 quarters since. 1,440 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • MGO One Seven held 10,875 shares of MetLife worth $920K as of Q2 2026.
  • MGO One Seven bought 80 MetLife shares in Q2 2026, an estimated $6.45K.
  • MetLife made up 0.02% of MGO One Seven's portfolio in Q2 2026, its #753 holding.
  • MGO One Seven first reported a position in MetLife in Q4 2017 and has held it in 11 quarters since.
  • 1,440 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.